 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
4 News |  |
- ||| LY3022856 / Eli Lilly
Trial completion, Trial primary completion date, Metastases: A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Aug 8, 2014
P1, N=60, Completed, Sponsor: Eli Lilly and Company
Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jul 2014
- || LY3022856 / Eli Lilly
Enrollment change, Metastases: A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Apr 8, 2013
P1, N=60, Recruiting, Sponsor: Eli Lilly and Company
Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jul 2014 N=40 --> 60